Clinical and molecular significance of the RNA m6A methyltransferase complex in prostate cancer
Jennifer Lothion‐Roy(University of Nottingham), Corinne L. Woodcock(University of Nottingham), Atara Ntekim(University College Hospital, Ibadan), Michael S. Toss(Nottingham City Hospital), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Emad A. Rakha(Nottingham University Hospitals NHS Trust), Catrin S. Rutland(University of Nottingham), Victoria James(University of Nottingham), Melissa L. Mather(University of Nottingham), Veronika M. Metzler(University of Nottingham), Nathan Archer(University of Nottingham), Lorraine J. Gudas(Cornell University), Yousif A. Kariri(University of Nottingham), Jennie Jeyapalan(University of Nottingham), Francesca Khani(Cornell University), Daisy B. Haigh(University of Nottingham), Mansour Alsaleem(University of Nottingham), Richard D. Emes(University of Nottingham), Cinzia Allegrucci(University of Nottingham), Nigel P. Mongan(University of Nottingham), Anna E. Harris(University of Nottingham), Brian D. Robinson(Cornell University), Rupert G. Fray(University of Nottingham)
Cited by 15
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
|The Lancet Oncology|2013|605
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
|Human Mutation|2006|404